ResApp Health |
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 16 November 2026 at 1:46am | ||||
|
Market Cap (16-Nov) $9,622,170 (1,192nd) |
Close (28-Sep) $0.205 |
Volume (28-Sep) 0 |
Shortsold (21-Sep) 297,501 (0.03%) (573rd) |
|
52w High $0.065 |
52w Low $0.009 |
P/E - |
EPS -0.01 |
COVID-19 Investor Presentation
RAP released this announcement to the ASX on 22 March 2022, 12:58. The announcement is not marked as price sensitive, and is 20 page(s) in length and 4.72MB in size.
You can view all announcements from RAP and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAP was 0.212% short sold according to ASIC data. It was ranked the 419th most shorted stock on the ASX. It remains ranked 573rd as of the latest reported data (21 September 2022).
| Other Recent Announcements from RAP | |
|---|---|
| Removal from Official List | 27 September 2022, 11:58 |
| Scheme of Arrangement has been Implemented | 26 September 2022, 16:28 |
| Ceasing to be a substantial holder | 20 September 2022, 8:09 |
| COVID-19 Investor Presentation | 22 March 2022, 12:58 |
| Reinstatement to Official Quotation | 22 March 2022, 9:40 |
| ResApp announces positive results of COVID-19 screening test | 22 March 2022, 9:39 |
| Suspension from Official Quotation | 21 March 2022, 11:43 |
If you were already registered, log in here.